Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.399 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.608 |
CLV_NRD_NRD_1 | 26 | 28 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.484 |
CLV_PCSK_KEX2_1 | 104 | 106 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.608 |
CLV_PCSK_KEX2_1 | 26 | 28 | PF00082 | 0.482 |
CLV_PCSK_KEX2_1 | 89 | 91 | PF00082 | 0.455 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.637 |
DOC_CYCLIN_yCln2_LP_2 | 49 | 55 | PF00134 | 0.357 |
DOC_MAPK_gen_1 | 89 | 100 | PF00069 | 0.460 |
LIG_14-3-3_CanoR_1 | 2 | 6 | PF00244 | 0.569 |
LIG_14-3-3_CterR_2 | 104 | 109 | PF00244 | 0.474 |
LIG_LIR_Nem_3 | 48 | 53 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.467 |
LIG_Pex14_2 | 12 | 16 | PF04695 | 0.620 |
LIG_SH2_CRK | 50 | 54 | PF00017 | 0.391 |
LIG_SH2_STAP1 | 55 | 59 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.339 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.324 |
LIG_WRC_WIRS_1 | 9 | 14 | PF05994 | 0.637 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.487 |
MOD_LATS_1 | 103 | 109 | PF00433 | 0.562 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.582 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.379 |
MOD_NEK2_2 | 45 | 50 | PF00069 | 0.479 |
MOD_NEK2_2 | 55 | 60 | PF00069 | 0.493 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.630 |
MOD_PKA_2 | 69 | 75 | PF00069 | 0.449 |
MOD_Plk_1 | 17 | 23 | PF00069 | 0.602 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.460 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.397 |
TRG_ENDOCYTIC_2 | 9 | 12 | PF00928 | 0.562 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.595 |
TRG_ER_diArg_1 | 104 | 106 | PF00400 | 0.544 |
TRG_ER_diArg_1 | 26 | 29 | PF00400 | 0.475 |
TRG_ER_diArg_1 | 88 | 90 | PF00400 | 0.487 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7D7 | Leptomonas seymouri | 85% | 100% |
A0A0S4J1X9 | Bodo saltans | 54% | 100% |
A0A1X0NKJ1 | Trypanosomatidae | 63% | 100% |
A0A3R7KZA1 | Trypanosoma rangeli | 61% | 74% |
A0A3S5H5X8 | Leishmania donovani | 99% | 100% |
A4H4Y8 | Leishmania braziliensis | 96% | 100% |
A4HT64 | Leishmania infantum | 99% | 100% |
C9ZJ32 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9AL53 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |